Journal Articles


1.     Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior.  Pediatrics. 2004 Feb;65(2):230-7


2.     Koren, G. Discontinuation syndrome following late pregnancy exposure to antidepressants. Arch Pediatr Adolesc Med 2004 Apr;158:307-8


3.     Kallen, B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med. 2004 Apr;158:312-16


4.     Stiskal JA, Kulin N, Koren G, Ho T, Ito S.  Neonatal paroxetine withdrawal syndrome.  Arch Dis Child Fetal Neonatal Ed. 2001 Mar;84(2):F134-5


5.     Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure.  Am J of Psychiatry. 2002 Dec;159(12):2055-61


6.     [No authors listed] Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. American Academy of Pediatrics Committee on Drugs.  Pediatrics. 4 Apr 2000. 105(4):880-6


7.     [No authors listed] Neonatal drug withdrawal.  American Academy of Pediatrics Committee on Drugs.  Pediatrics. 1998 Jun; 101(6):1079-88.  Erratum in: Pediatrics 1998 Sep; 102(3 Pt 1):660. 


8.     Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E. Pharmacologic Treatment of Depression During Pregnancy. JAMA 6 Oct 1999. 282(13):1264-9


9.     Wisner KL, Zarin DA, Holmboe ES, Appelbaum PS, Gelenberg AJ, Leonard HL, Frank E. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry. 2000 Dec;157(12):1933-40.